AgelessRx has launched GHK-Cu Cream, a prescription copper peptide cream the company says is designed to support tissue repair and renewal that changes with age. It is available now to eligible adults, with pricing starting at $99 per month.

GHK-Cu is a copper peptide, and the product arrives in two clinician-guided concentrations, 0.5% and 3%. AgelessRx says the two strengths exist so a provider can pick a starting point based on patient history, treatment area and tolerance.

Compounded, not approved

The cream is compounded by licensed U.S. pharmacies, and compounded medications are not FDA-approved. That is stated plainly in the announcement, which is more candor than this corner of the market usually offers, and it is the single most important line for anyone reading the launch copy.

Every prescription requires review by a licensed medical provider, and the company says the purchase includes ongoing clinical support. In other words this is a telehealth product with a gatekeeper attached, not a shelf item.

What the purity numbers cover

AgelessRx says laboratory testing confirmed 99.8% purity and that the product passed microbial and endotoxin testing. Those are manufacturing figures, and they are worth something: contamination and mislabeled content are the recurring failure mode in peptide products sold outside a pharmacy chain.

They are not efficacy figures, and it is worth being clear about the difference. A cream can be 99.8% what it says it is and still have no published outcome data behind the claim on the box.

Where the evidence stops

No clinical trial of this cream appears in the announcement. The research credentials cited belong to the company rather than the product: AgelessRx says its in-house team has run more than 11 longevity trials, published nine peer-reviewed papers, and took a Top 10 Milestone 2 Award in the XPRIZE Healthspan competition in August 2026.

That is a real track record and it is also a different thing from a study of this formulation at these concentrations. Until one exists, the strongest supportable statement is the company's own framing of what the cream is designed to do.

Bottom line

A pharmacy-compounded copper peptide behind a prescriber review is a more serious version of a product category that mostly sells itself on vibes. What remains unsettled is whether either concentration does anything a published trial can measure.